Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Korean J Ophthalmol. 2022 Dec;36(6):509-517. doi: 10.3341/kjo.2022.0051. Epub 2022 Oct 11.
To compare the diagnosis and treatment outcome of lacrimal drainage obstruction of patients who underwent systemic chemotherapy (CTx) or radioactive iodine treatment (RAI) by using dacryoendoscopy and at the same time performing dacryoendoscopy-guided silicone tube insertion (STI) to treat epiphora.
From July 2017 to December 2020, the medical records of 11 patients (16 eyes) were diagnosed with lacrimal drainage obstruction after CTx or RAI and underwent dacryoendoscopy-guided STI were reviewed retrospectively. We tried to count the number of obstructive sites in total patients using slit-lamp examination and dacryoendoscopic findings.
A total of 11 patients, 16 eyes, were enrolled in this study. The onset of epiphora in the CTx group (3.0 ± 4.0 months) was significantly shorter than that in the RAI group (52.6 ± 36.5 months, p = 0.001). There were total 32 obstructive sites including 28 obstructive sites of dacryoendoscopic findings and four sites of punctual stenosis in total 16 cases. Using dacryoendoscopy, granulation findings was dominant in RAI patients (p = 0.038) and mucus finding was frequent mostly in lacrimal sac and canaliculus. In the CTx group, mucosal edema finding was dominant (p = 0.038) and fibrotic membrane finding was frequent in all levels of lacrimal drainage system. Regarding the obstructive location, lacrimal sac was the most frequently obstructed site in the two groups (p = 0.038).
The onset of epiphora in the CTx group was significantly earlier than in the RAI group. In the CTx group, mucosal edema finding was frequent in all levels of lacrimal drainage system. In the RAI group, granulation finding was frequent mostly in lacrimal sac and canaliculus. Since the clinical outcome was satisfactory, intervention with dacryoendoscopy-guided STI could be a treatment of choice in patients with epiphora after CTx or RAI.
比较行全身化疗(CTx)或放射性碘治疗(RAI)后,通过泪道内窥镜检查同时行泪道内窥镜引导下硅胶管插入术(STI)治疗溢泪的患者的诊断和治疗结果。
回顾性分析 2017 年 7 月至 2020 年 12 月,11 例(16 只眼)经 CTx 或 RAI 诊断为泪道阻塞后行泪道内窥镜引导下 STI 的患者的病历。我们试图通过裂隙灯检查和泪道内窥镜检查结果计算患者的总阻塞部位数。
共纳入 11 例患者(16 只眼)。CTx 组溢泪的发病时间(3.0±4.0 个月)明显短于 RAI 组(52.6±36.5 个月,p=0.001)。在 16 例患者中,总共有 32 个阻塞部位,其中 28 个阻塞部位为泪道内窥镜检查所见,4 个为泪小点狭窄。应用泪道内窥镜,RAI 患者中肉芽组织发现更为常见(p=0.038),泪囊和泪小管中常发现黏液。CTx 组中,黏膜水肿发现更为常见(p=0.038),纤维化膜发现常见于各级泪道系统。关于阻塞位置,两组中泪囊均为最常阻塞部位(p=0.038)。
CTx 组溢泪的发病时间明显早于 RAI 组。CTx 组各级泪道系统均有黏膜水肿。RAI 组泪囊和泪小管中常发现肉芽组织。由于临床效果满意,泪道内窥镜引导下 STI 干预可能是 CTx 或 RAI 后溢泪患者的治疗选择。